Search clinical trials for: Lenalidomide (Control)
Total 65865 results
-
University of BolognaTerminated
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Robert Dreicer MDNational Cancer Institute (NCI)Completed
-
Seoul National University HospitalCompletedAmyloidosis CardiacKorea, Republic of
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Institut Paoli-CalmettesCompletedAcute Myeloid Leukemia or Myelodysplasic SyndromeFrance
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
Fudan UniversityCompletedDouble Expressor LymphomaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, France, Australia
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
LiNingNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingNeoplasms by Histologic Type | Lymphoma, Large B-Cell, DiffuseChina
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminatedChronic Lymphocytic LeukemiaItaly
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
Institut CurieNational Cancer Institute, FranceRecruitingLymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, PrimaryFrance
-
University of California, San DiegoCompletedCLL | Richter's SyndromeUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownMyelodysplastic SyndromeIsrael
-
University Hospital, EssenCelgeneCompletedB-cell LymphomaGermany
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia